---
reference_id: "PMID:18292996"
title: Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
authors:
- Langer F
- Spath B
- Haubold K
- Holstein K
- Marx G
- Wierecky J
- Br체mmendorf TH
- Dierlamm J
- Bokemeyer C
- Eifrig B
journal: Ann Hematol
year: '2008'
doi: 10.1007/s00277-008-0446-3
content_type: abstract_only
---

# Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
**Authors:** Langer F, Spath B, Haubold K, Holstein K, Marx G, Wierecky J, Br체mmendorf TH, Dierlamm J, Bokemeyer C, Eifrig B
**Journal:** Ann Hematol (2008)
**DOI:** [10.1007/s00277-008-0446-3](https://doi.org/10.1007/s00277-008-0446-3)

## Content

1. Ann Hematol. 2008 Jun;87(6):451-7. doi: 10.1007/s00277-008-0446-3. Epub 2008
Feb  22.

Tissue factor procoagulant activity of plasma microparticles in patients with 
cancer-associated disseminated intravascular coagulation.

Langer F(1), Spath B, Haubold K, Holstein K, Marx G, Wierecky J, Br체mmendorf TH, 
Dierlamm J, Bokemeyer C, Eifrig B.

Author information:
(1)Onkologisches Zentrum, II. Medizinische Klinik und Poliklinik, 
Universit채tsklinikum Hamburg-Eppendorf, 20246 Hamburg, Germany. 
langer@uke.uni-hamburg.de

Tissue factor (TF) expressed on sub-cellular membrane vesicles, so-called plasma 
microparticles (MPs), has recently emerged as a potential key player in 
intravascular coagulation activation in various disease states. In this report, 
we demonstrate significantly increased levels of TF-specific procoagulant 
activity (PCA) of plasma MPs in five patients presenting with overt disseminated 
intravascular coagulation (DIC) due to an underlying malignancy, including 
non-small-cell lung cancer (n = 1), melanoma (n = 1), prostate cancer (n = 2), 
and acute promyelocytic leukemia (n = 1). Clotting experiments on available 
tumor cell samples suggested that cancer cells were a potential source of 
circulating TF-positive MPs at least in three of the five patients. Furthermore, 
follow-up plasma samples from two surviving patients revealed that response of 
their malignancies to specific anti-cancer therapy was paralleled by resolution 
of overt DIC and a significant decline in MP-associated TF PCA. Levels of plasma 
TF antigen, as assessed by an enzyme-linked immunosorbent assay, were also 
increased at presentation albeit to a lesser extent compared to MP-associated TF 
PCA, likely due to insufficient solubilization of the phospholipid-incorporated 
full-length TF molecule by the detergent. In summary, our findings suggest that 
MP-associated TF PCA may play an important pathogenic role in the evolution of 
overt DIC in various types of malignancy.

DOI: 10.1007/s00277-008-0446-3
PMID: 18292996 [Indexed for MEDLINE]